Technology
Health
Biotechnology

Trillium Therapeutics

2,685

$4.06
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.06 (+1.50%) As of 1:29 PM EDT today
+$0.06 (+1.50%) Today

Why Robinhood?

You can buy or sell TRIL and other stocks, options, ETFs, and crypto commission-free!

About TRIL

Trillium Therapeutics Inc. Common Shares, also called Trillium Therapeutics, is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. Read More Its pipeline is comprised of TTI-621, TTI-622, and TTI-10001 (Sting Agonist). The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada.

CEO
Jan Skvarka
Employees
29
Headquarters
Mississauga, Ontario
Founded
2004
Market Cap
300.70M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.16M
High Today
$4.29
Low Today
$3.90
Open Price
$4.25
Volume
788.31K
52 Week High
$7.97
52 Week Low
$0.2405

Collections

Technology
Health
Biotechnology
Therapy
Medical
Cancer Prevention
2014 IPO
Canada

TRIL Earnings

-$0.91
-$0.61
-$0.30
$0.00
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 27, Pre-Market

People Also Bought

Onconova Therapeutics

26,687

$0.2919

+1.07%

Onconova Therapeutics

26,687

$0.2919

+1.07%

FuelCell Energy

58,641

$1.50

+4.55%

Advaxis

11,765

$0.6201

-1.57%

Titan Pharmaceuticals

37,346

$0.2234

-1.59%

You May Also Like

TLYS
URNM
SBM
STRL
SMLV
UONE
GLW
BKTI
JHMD
APTS
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy TRIL

Market Price$4.06
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell TRIL stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up